Miller JS - Search Results

1

A tri-specific killer engager against mesothelin targets NK cells towards lung cancer.

Kennedy PR, Vallera DA, Ettestad B, Hallstrom C, Kodal B, Todhunter DA, Bendzick L, Hinderlie P, Walker JT, Pulkrabek B, Pastan I, Kratzke RA, Fujioka N, Miller JS, Felices M. Kennedy PR, et al. Among authors: miller js. Front Immunol. 2023 Feb 22;14:1060905. doi: 10.3389/fimmu.2023.1060905. eCollection 2023. Front Immunol. 2023. PMID: 36911670 Free PMC article.

2

Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor.

Miller JS, Cervenka T, Lund J, Okazaki IJ, Moss J. Miller JS, et al. J Immunol. 1999 Jun 15;162(12):7376-82. J Immunol. 1999. PMID: 10358189

3

Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis.

Lickliter JD, Kratzke RA, Nguyen PL, Niehans GA, Miller JS. Lickliter JD, et al. Among authors: miller js. Exp Hematol. 1999 Oct;27(10):1519-27. doi: 10.1016/s0301-472x(99)00091-0. Exp Hematol. 1999. PMID: 10517493 Free article.

4

Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.

Cooley S, Burns LJ, Repka T, Miller JS. Cooley S, et al. Among authors: miller js. Exp Hematol. 1999 Oct;27(10):1533-41. doi: 10.1016/s0301-472x(99)00089-2. Exp Hematol. 1999. PMID: 10517495 Free article.

5

The biology of natural killer cells and implications for therapy of human disease.

Chiorean EG, Miller JS. Chiorean EG, et al. Among authors: miller js. J Hematother Stem Cell Res. 2001 Aug;10(4):451-63. doi: 10.1089/15258160152509073. J Hematother Stem Cell Res. 2001. PMID: 11522229 Review.

6

The biology of natural killer cells in cancer, infection, and pregnancy.

Miller JS. Miller JS. Exp Hematol. 2001 Oct;29(10):1157-68. doi: 10.1016/s0301-472x(01)00696-8. Exp Hematol. 2001. PMID: 11602317 Free article. Review.

7

The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients.

Nakajima H, Zhao R, Lund TC, Ward J, Dolan M, Hirsch B, Miller JS. Nakajima H, et al. Among authors: miller js. J Immunol. 2002 Jan 15;168(2):643-50. doi: 10.4049/jimmunol.168.2.643. J Immunol. 2002. PMID: 11777957

8

Biology of natural killer cells in cancer and infection.

Miller JS. Miller JS. Cancer Invest. 2002;20(3):405-19. doi: 10.1081/cnv-120001185. Cancer Invest. 2002. PMID: 12025235 Review.

9

BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs).

Chiorean EG, Dylla SJ, Olsen K, Lenvik T, Soignier Y, Miller JS. Chiorean EG, et al. Among authors: miller js. Blood. 2003 May 1;101(9):3527-33. doi: 10.1182/blood-2002-04-1172. Epub 2003 Jan 2. Blood. 2003. PMID: 12511422 Free article.

10

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.

Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, McKenna D, Le C, Defor TE, Burns LJ, Orchard PJ, Blazar BR, Wagner JE, Slungaard A, Weisdorf DJ, Okazaki IJ, McGlave PB. Miller JS, et al. Blood. 2005 Apr 15;105(8):3051-7. doi: 10.1182/blood-2004-07-2974. Epub 2005 Jan 4. Blood. 2005. PMID: 15632206 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,124 results

Search Page